November 24, 2014

American Well is among the first healthcare providers to see an uptick in online visits associated with influenza-like symptoms.

November 24, 2014

Endo on Monday announced the acquisition of rights to Natesto (testosterone nasal gel), a testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism. 

November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

November 19, 2014

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

November 17, 2014

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

November 17, 2014

A recent study by Field Agent examined what consumers are planning to do to keep themselves and their families healthy this fall.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

November 17, 2014

In this issue, we explore the profile of health-seeking drug store shoppers, their pharmacy purchase behavior and the best times to reach this valuable audience with promotional messages.

November 13, 2014

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

November 13, 2014

A new analysis released by Avalere Health Thursday found that Medicare Part D prescription drug plans are poised to increase significantly the use of coinsurance in 2015. 

November 12, 2014

Drug Store News caught up with Rite Aid's Robert Thompson to discuss the impact Vaccine Central will have on raising immunization awareness. 

 

November 10, 2014

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

November 10, 2014

A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 

November 7, 2014

Janssen Therapeutics announced earlier this week that the Food and Drug Administration approved Olysio (simeprevir), a hepatitis C virus NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen. 

November 7, 2014

Mylan on Friday announced that it has signed an agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a severe allergic reaction. 

November 7, 2014

Perrigo may one day expand into the branded side of the U.S. OTC business, Joseph Papa, Perrigo president, chairman and CEO, told analysts Thursday morning.

November 7, 2014

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.

November 6, 2014

A Belgian healthcare website recently presented the lighter side of researching medical conditions on Google. 

November 5, 2014

Novo Nordisk on Wednesday announced the relaunch of Cornerstones4Care, an online patient support platform for people living with diabetes.

November 5, 2014

Excellus BlueCross BlueShield patients can now have prescriptions filled at Wegmans, with free home delivery.